Sarah Krepp Sells 4,557 Shares of Liquidia (NASDAQ:LQDA) Stock

Key Points

• Sarah Krepp sold 4,557 shares of Liquidia on April 13 at an average price of $38.37 for about $174,852, lowering her direct stake to 147,019 shares (a 3.01% decrease); the sale was disclosed in an SEC filing and was made to cover tax withholding from vesting equity awards.
• Liquidia beat expectations last quarter with EPS of $0.15 (vs. $0.08 expected) and revenue of $92.02M (up 3,072% YoY) but still reports negative margins and ROE; analysts maintain a “Moderate Buy” consensus with an average price target of $43.44 and several firms raising targets or ratings.

Liquidia Corporation (NASDAQ:LQDA - Get Free Report) insider Sarah Krepp sold 4,557 shares of the business's stock in a transaction dated Monday, April 13th. The stock was sold at an average price of $38.37, for a total transaction of $174,852.09. Following the completion of the transaction, the insider directly owned 147,019 shares of the company's stock, valued at approximately $5,641,119.03. This represents a 3.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Liquidia Price Performance

Shares of LQDA traded down $0.14 during mid-day trading on Tuesday, hitting $38.71. 844,813 shares of the company traded hands, compared to its average volume of 1,775,539. The company has a current ratio of 2.01, a quick ratio of 1.84 and a debt-to-equity ratio of 2.97. The stock has a market capitalization of $3.41 billion, a price-to-earnings ratio of -46.64 and a beta of 0.45. The business has a 50-day moving average of $36.87 and a 200 day moving average of $32.92. Liquidia Corporation has a one year low of $11.85 and a one year high of $46.67.

Liquidia (NASDAQ:LQDA - Get Free Report) last posted its quarterly earnings data on Thursday, March 5th. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.07. Liquidia had a negative net margin of 43.53% and a negative return on equity of 209.33%. The firm had revenue of $92.02 million during the quarter, compared to analysts' expectations of $87.49 million. The company's revenue for the quarter was up 3072.4% compared to the same quarter last year. As a group, equities analysts expect that Liquidia Corporation will post -1.51 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on LQDA. Needham & Company LLC raised their price target on Liquidia from $52.00 to $54.00 and gave the company a "buy" rating in a report on Thursday, March 5th. Raymond James Financial reissued a "strong-buy" rating on shares of Liquidia in a report on Thursday, March 5th. Wells Fargo & Company raised their target price on shares of Liquidia from $44.00 to $51.00 and gave the company an "overweight" rating in a research note on Monday, March 23rd. Weiss Ratings reiterated a "sell (d-)" rating on shares of Liquidia in a research report on Thursday, January 22nd. Finally, Lifesci Capital raised shares of Liquidia to a "strong-buy" rating in a research note on Thursday, March 5th. Two investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $43.44.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in LQDA. Northwestern Mutual Wealth Management Co. acquired a new stake in shares of Liquidia during the fourth quarter worth $25,000. Covestor Ltd lifted its stake in Liquidia by 41.9% in the fourth quarter. Covestor Ltd now owns 1,216 shares of the company's stock valued at $42,000 after buying an additional 359 shares during the period. Skandinaviska Enskilda Banken AB publ acquired a new position in Liquidia in the third quarter valued at about $30,000. FNY Investment Advisers LLC bought a new position in Liquidia during the third quarter worth about $34,000. Finally, NewEdge Advisors LLC bought a new position in Liquidia during the second quarter worth about $25,000. 64.54% of the stock is currently owned by institutional investors.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company's lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.